BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30231287)

  • 1. [Hormone Replacement Therapy in Males].
    Zitzmann M
    Dtsch Med Wochenschr; 2018 Sep; 143(19):1405-1416. PubMed ID: 30231287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Testosterone replacement treatment in older people with and without co-morbidities].
    Zitzmann M
    Internist (Berl); 2020 Jun; 61(6):549-557. PubMed ID: 32377774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
    Lunenfeld B; Mskhalaya G; Zitzmann M; Arver S; Kalinchenko S; Tishova Y; Morgentaler A
    Aging Male; 2015 Mar; 18(1):5-15. PubMed ID: 25657080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
    Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
    J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone replacement therapy: For whom, when and how?
    Tsametis CP; Isidori AM
    Metabolism; 2018 Sep; 86():69-78. PubMed ID: 29530796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of the "aging male"].
    Diemer T; Hauck EW; Rohde V; Weidner W
    Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical hypogonadism and androgen replacement therapy: an overview.
    Ohl DA; Quallich SA
    Urol Nurs; 2006 Aug; 26(4):253-9, 269; quiz 260. PubMed ID: 16939042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of male hypogonadism].
    Zitzmann M
    Internist (Berl); 2008 May; 49(5):559-60, 562-4, 566-9. PubMed ID: 18351310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of testosterone therapy in older men.
    Cardona Attard C; Fava S
    Minerva Urol Nefrol; 2019 Jun; 71(3):217-229. PubMed ID: 30700083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Testosterone substitution with special regard to prostate cancer].
    Beintker M; Behre H
    Urologe A; 2008 Dec; 47(12):1588-91. PubMed ID: 18931991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotestosteronaemia in the aging male: should we treat it?
    Christe N; Meier CA
    Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy.
    Yeap BB; Grossmann M; McLachlan RI; Handelsman DJ; Wittert GA; Conway AJ; Stuckey BG; Lording DW; Allan CA; Zajac JD; Burger HG
    Med J Aust; 2016 Aug; 205(4):173-8. PubMed ID: 27510348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
    Traish A
    Investig Clin Urol; 2016 Nov; 57(6):384-400. PubMed ID: 27847912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.
    Conners WP; Morgentaler A
    Curr Urol Rep; 2013 Dec; 14(6):557-64. PubMed ID: 23999611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-induced hypogonadism: why and how to treat it.
    De Maddalena C; Bellini M; Berra M; Meriggiola MC; Aloisi AM
    Pain Physician; 2012 Jul; 15(3 Suppl):ES111-8. PubMed ID: 22786450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset hypogonadism: metabolic impact.
    Grossmann M; Ng Tang Fui M; Cheung AS
    Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
    Brunton SA; Sadovsky R
    J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.